So in November, I posed a question to management and policy experts: Could Musk's history of ruthlessly slimming down his ...

Q4 2024 Earnings Call Transcript March 3, 2025 Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $ ...

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which phlebotomy-dependent ...